Suppr超能文献

通过大规模疫苗接种控制流行性脑膜炎球菌性脑膜炎。II. 疫苗接种四年后抗体的持久性。

Control of epidemic meningococcal meningitis by mass vaccination. II. Persistence of antibody four years after vaccination.

作者信息

Mohammed I, Onyemelukwe G C, Obineche E N, Gupta N, Oyeyinka G O

出版信息

J Infect. 1984 Sep;9(2):197-202. doi: 10.1016/s0163-4453(84)91468-3.

Abstract

Meningococcal antibody was measured in 928 persons vaccinated with combined groups A and C polysaccharide antigens in Bauchi State, Nigeria between 1979 and 1982. Protective amounts of antibody were detected by the indirect haemagglutination technique up to 4 years after vaccination. This persistence was observed mainly in adults, although a substantial proportion of older children also had persistent antibody. Titres in younger children fell progressively, and by the third year the mean log2 antibody titre was 1.4; this may not confer protection against disease. A rational policy for vaccination against meningococcal meningitis would be to revaccinate younger children after 2 years, older children after 4 years, and adults after 6-8 or more years.

摘要

1979年至1982年间,在尼日利亚包奇州对928名接种A群和C群多糖联合抗原疫苗的人进行了脑膜炎球菌抗体检测。通过间接血凝技术在接种疫苗后长达4年的时间里检测到了具有保护作用的抗体量。这种抗体持久性主要在成年人中观察到,不过相当一部分大龄儿童也有持久性抗体。年幼儿童的抗体滴度逐渐下降,到第三年时,平均log2抗体滴度为1.4;这可能无法提供针对疾病的保护。针对脑膜炎球菌性脑膜炎的合理疫苗接种策略是,2年后对年幼儿童进行再次接种,4年后对大龄儿童进行再次接种,6至8年或更长时间后对成年人进行再次接种。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验